Doyle Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $4.66M | Buy |
34,715
+599
| +2% | +$80.4K | 0.4% | 60 |
|
|
2022
Q2 | $5.23M | Sell |
34,116
-1,122
| -3% | -$172K | 0.42% | 63 |
|
|
2022
Q1 | $5.71M | Buy |
35,238
+1,293
| +4% | +$210K | 0.41% | 64 |
|
|
2021
Q4 | $4.6M | Buy |
33,945
+1,519
| +5% | +$206K | 0.33% | 65 |
|
|
2021
Q3 | $3.5M | Buy |
32,426
+2,481
| +8% | +$268K | 0.28% | 69 |
|
|
2021
Q2 | $3.37M | Buy |
29,945
+2,619
| +10% | +$295K | 0.28% | 70 |
|
|
2021
Q1 | $2.96M | Buy |
27,326
+1,586
| +6% | +$172K | 0.28% | 68 |
|
|
2020
Q4 | $2.76M | Buy |
25,740
+19,713
| +327% | +$2.11M | 0.28% | 68 |
|
|
2020
Q3 | $528K | Buy |
6,027
+497
| +9% | +$43.5K | 0.06% | 124 |
|
|
2020
Q2 | $543K | Sell |
5,530
-228
| -4% | -$22.4K | 0.07% | 111 |
|
|
2020
Q1 | $439K | Buy |
5,758
+810
| +16% | +$61.8K | 0.07% | 112 |
|
|
2019
Q4 | $438K | Buy |
4,948
+108
| +2% | +$9.56K | 0.05% | 133 |
|
|
2019
Q3 | $366K | Buy |
4,840
+1,625
| +51% | +$123K | 0.05% | 140 |
|
|
2019
Q2 | $234K | Buy |
3,215
+6
| +0.2% | +$437 | 0.03% | 177 |
|
|
2019
Q1 | $249K | Sell |
3,209
-3,627
| -53% | -$281K | 0.04% | 167 |
|
|
2018
Q4 | $630K | Buy |
6,836
+779
| +13% | +$71.8K | 0.11% | 87 |
|
|
2018
Q3 | $573K | Sell |
6,057
-61,757
| -91% | -$5.84M | 0.09% | 101 |
|
|
2018
Q2 | $6.28M | Sell |
67,814
-1,263
| -2% | -$117K | 1.04% | 39 |
|
|
2018
Q1 | $6.54M | Sell |
69,077
-331
| -0.5% | -$31.3K | 1.1% | 35 |
|
|
2017
Q4 | $6.71M | Sell |
69,408
-2,091
| -3% | -$202K | 1.13% | 34 |
|
|
2017
Q3 | $6.35M | Sell |
71,499
-52,317
| -42% | -$4.65M | 1.11% | 36 |
|
|
2017
Q2 | $8.98M | Buy |
123,816
+3,427
| +3% | +$248K | 1.66% | 25 |
|
|
2017
Q1 | $7.85M | Buy |
+120,389
| New | +$7.85M | 1.6% | 23 |
|